Tyra Biosciences, Inc. Share Price
TYRATyra Biosciences, Inc. Stock Performance
Open $36.68 | Prev. Close $36.81 | Circuit Range N/A |
Day Range $35.00 - $36.68 | Year Range $7.07 - $40.42 | Volume 9,964 |
Average Traded $35.76 |
Tyra Biosciences, Inc. Share Price Chart
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Tyra Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $38.23 | $37.12 | -1.49% |
07-Apr-26 | $38.63 | $37.68 | -3.16% |
06-Apr-26 | $40.16 | $38.91 | -1.79% |
02-Apr-26 | $37.19 | $39.62 | +3.49% |
01-Apr-26 | $39.45 | $38.28 | -0.07% |
31-Mar-26 | $36.68 | $38.31 | +10.95% |
30-Mar-26 | $35.72 | $34.53 | -4.93% |